Qatar Investment Authority filed a Schedule 13G with the SEC on November 3, 2026, disclosing a 6.7% beneficial ownership position in Aspen Neuroscience, Inc. (NASDAQ:ASPE) as of an event date of October 30, 2026.

Key Highlights

  • Beneficial ownership: Qatar Investment Authority reported beneficial ownership of 1,933,330 shares of Aspen Neuroscience common stock.
  • Percent of class: The 1,933,330 shares represent 6.7% of the outstanding class, according to the filing.
  • Sole voting and dispositive power: Qatar Investment Authority holds sole voting power and sole dispositive power over all 1,933,330 shares, with no shared voting or dispositive power reported.
  • Acquiring subsidiary: The filing discloses that Q Healthcare Holding LLC, described as a wholly owned subsidiary of Qatar Investment Authority, is the entity that acquired the securities.
  • Triggering event: The date of the event requiring the filing is stated as October 30, 2026.
  • Certification: The filing certifies that the securities "were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

Qatar Investment Authority Reports Crossing of 5% Threshold in Aspen Neuroscience

Qatar Investment Authority, a sovereign wealth fund organized in Qatar and headquartered at Ooredoo Tower in Doha, filed a Schedule 13G with the Securities and Exchange Commission on November 3, 2026, reporting beneficial ownership of 1,933,330 shares of Aspen Neuroscience, Inc. common stock (par value $0.0001 per share, CUSIP 044933109). The filing was triggered by an event occurring on October 30, 2026. Aspen Neuroscience, Inc. is listed on NASDAQ:ASPE and maintains its principal executive offices at 10835 Road to the Cure, Suite 100, San Diego, California, 92121, according to the filing.

According to the Schedule 13G, all 1,933,330 shares carry sole voting power and sole dispositive power held by Qatar Investment Authority, with zero shares subject to shared voting or shared dispositive arrangements. The filing identifies Q Healthcare Holding LLC as the wholly owned subsidiary of Qatar Investment Authority through which the securities were acquired. The filing was signed by Mohammed Fahad Al Khulaifi, identified as Head of Compliance and Governance, on November 3, 2026.

In the required certification under Item 10, Qatar Investment Authority stated that the securities "were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11." The filing did not indicate membership in a group, and Items 8 and 9 regarding group membership and dissolution were each marked not applicable.

What Was Disclosed

Qatar Investment Authority disclosed a 6.7% beneficial ownership stake of 1,933,330 shares in Aspen Neuroscience, Inc., acquired through its wholly owned subsidiary Q Healthcare Holding LLC, as reported in a Schedule 13G filed November 3, 2026.